Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01648465
Recruitment Status : Terminated
First Posted : July 24, 2012
Last Update Posted : September 2, 2019
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Hellenic Cooperative Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 2017
Actual Study Completion Date : August 6, 2019